Continental AG Has Decided Not to Present Vitesco Technologies Spin-off at Annual Shareholders’ Meeting . Eine zumindest sehr wahrscheinliche Übervorteilung des Mehrheitsaktionärs zulasten der Minderheitsaktionäre konnte selbst auf juristischem Weg nicht zweifelsfrei festgestellt werden.

info@biontech.de, We aspire to individualize cancer medicine, Our vision: individualize cancer medicine, How we approach individualized cancer medicine, Why mRNA represents a disruptive new drug class, Beyond mRNA: Expanding therapeutics with our antibody discovery engines, Explore our individualized immunotherapy pipeline, Tour our platforms that produce individually-tailored therapeutics, Our Mission: broaden the therapeutic universe to benefit patients. Investor Relations. You can change your cookie settings at any time by visiting our Cookie Policy or by clearing the cache in your browser. An der Goldgrube 12 Fact Books back to 2008 as PDF files for download. 10.07.2020: NORDWEST Handel AG: Stabile Entwicklung trotz schwieriger Rahmenbedingungen 07.07.2020: NORDWEST-Konzern: Gute Entwicklung des Geschäftsvolumens in schwierigen Zeiten 09.04.2020: NORDWEST Handel AG: Gute Umsatzentwicklung in schwierigen Zeiten Aktuelle Termine . The Continental bearer shares can be transferred on-exchange on several German stock exchanges or over-the-counter in the U.S.A.. For U.S. Investors: Westwicke Victoria Meissner, M.D. Seit diesem Zeitpunkt verlauten erstmalig seit der Übernahme der Aktienmehrheit durch Dr. Dr. Michael Tojner nur Molltöne bei den Zukunftsaussichten der Gesellschaft. Download the PDF version of the most recent Annual Report of Continental Aktiengesellschaft. On August 5, Continental released its H1 2020 results. BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. On August 5, Continental released its H1 2020 results. a montana tech components company By using this website, you agree to cookies (including those of third parties) being stored on your device in order to improve navigation on the website, to analyse the use of the website, and to support our marketing activities. This framework programme enables Continental to flexibly place medium term and long term bonds. Dieser Preis wurde seit der Aufnahme des Handels der Papiere der Montanatech im Jahr 2009 nicht annähernd erreicht. Die Montana Tech Components AG (MTC-Gruppe) nutzt, wie wir bereits vor zwei Wochen hier publizierten ... Wir können daher nur die Medienmitteilung der Gesellschaft sowie die Aussagen der Investor Relations Abteilung wiedergeben. Investor Relations Aktuelle Meldungen. F: +49 6131 9084-390 The outlook was withdrawn on April 1, 2020. Click on "Accept all" to allow all cookies or "Change cookie settings" to decide individually. € zum ersten Termin . Media Contact Jasmina Alatovic Senior Manager Global External Communications Media@biontech.de +49 6131 9084-1513 . From our roots in Mainz, Germany, we are driven to become the leading global biotechnology company for individualized cancer medicine. Announcement of Managers' Transactions Pursuant to Section 19 (Directors' Dealings) of the EU Market Abuse Act. Free float of 54.0%, major shareholder IHO Group 46%. We use cookies to provide basic and convenience functionalities, measure website performance and analyze user behavior on the website. Required cookies are always activated because they are indispensable for the operation of the website and to store your cookie consent.